| Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma (NCT00811759) | Gustave Roussy, Cancer Campus, Grand Paris | 2007-06-01 |
| Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma (NCT00538005) | San Diego Pacific Oncology & Hematology Associates | 2007-05-01 |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer (NCT00492440) | Cytheris SA | 2007-05-01 |
| Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation (NCT00471133) | Ichor Medical Systems Incorporated | 2007-04-01 |
| Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma (NCT00492505) | San Diego Pacific Oncology & Hematology Associates | 2007-04-01 |
| Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma (NCT00462982) | Memorial Sloan Kettering Cancer Center | 2007-03-01 |
| Vaccine Therapy and GM-CSF With or Without Low-Dose Aldesleukin in Treating Patients With Stage II, Stage III, or Stage IV Melanoma (NCT00470015) | Mayo Clinic | 2007-03-01 |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00667641) | University of Medicine and Dentistry of New Jersey | 2007-03-01 |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery (NCT00667901) | University of Medicine and Dentistry of New Jersey | 2007-02-01 |
| Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma (NCT00471887) | Jonsson Comprehensive Cancer Center | 2007-01-01 |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy (NCT00897481) | Leeds Cancer Centre at St. James's University Hospital | 2007-01-01 |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer (NCT00436410) | National Institutes of Health Clinical Center (CC) | 2006-12-01 |
| Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma (NCT00436930) | Hoag Memorial Hospital Presbyterian | 2006-12-01 |
| Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma (NCT00398073) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00390338) | Pawel Kalinski | 2006-10-01 |
| Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions (NCT00391300) | Eastern Virginia Medical School | 2006-10-01 |
| Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery (NCT00404235) | Alliance for Clinical Trials in Oncology | 2006-10-01 |
| Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma (NCT00568451) | Mayo Clinic | 2006-06-01 |
| Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma (NCT00357461) | Bristol-Myers Squibb | 2006-05-01 |
| Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial (NCT00316901) | National Institutes of Health Clinical Center (CC) | 2006-04-01 |
| Investigation of a Behavioral Substitute for Sunbathing (NCT00403377) | University of Massachusetts, Worcester | 2006-04-01 |
| Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery (NCT00470379) | Mayo Clinic | 2006-04-01 |
| Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma (NCT01018004) | University Medical Center Groningen | 2006-03-01 |
| Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin (NCT00453050) | University of Oklahoma | 2006-03-01 |
| Dendritic Cell Vaccination During Lymphoid Reconstruction (NCT00313508) | H. Lee Moffitt Cancer Center and Research Institute | 2006-02-01 |
| Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery (NCT00563823) | Cambridge University Hospitals NHS Foundation Trust | 2006-02-01 |
| Azacitidine and Interferon Alfa in Treating Patients With Metastatic Melanoma (NCT00398450) | University of California, San Diego | 2006-02-01 |
| LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery (NCT00295958) | National Institutes of Health Clinical Center (CC) | 2005-12-01 |
| Radiofrequency Therapy-Induced Endogenous Heat-Shock Proteins With or Without Radiofrequency Ablation or Cryotherapy in Treating Patients With Stage IV Melanoma (NCT00568763) | Mayo Clinic | 2005-11-25 |
| Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer (NCT00276835) | Northwestern University | 2005-11-01 |
| Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma (NCT00324623) | Prof. Serge Leyvraz | 2005-09-01 |
| Vaccine Therapy in Treating Patients With Malignant Melanoma (NCT00128583) | CancerVax Corporation | 2005-07-01 |
| Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery (NCT00278122) | University of Virginia | 2005-07-01 |
| Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma (NCT00138229) | National Institutes of Health Clinical Center (CC) | 2005-07-01 |
| S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery (NCT00104988) | SWOG Cancer Research Network | 2005-06-01 |
| Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma (NCT00071981) | Eastern Cooperative Oncology Group | 2005-05-09 |
| Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma (NCT00109863) | University of Wisconsin, Madison | 2005-05-01 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00126685) | Dermatologische Klinik MIT Poliklinik-Universitaetsklinikum Erlangen | 2005-04-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Malignant Melanoma (NCT00104897) | Cancer Research UK | 2005-03-01 |
| Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma (NCT00118274) | Craig L Slingluff, Jr | 2005-03-01 |
| Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma (NCT00107159) | Jonsson Comprehensive Cancer Center | 2005-01-01 |
| Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma (NCT00118313) | Craig L Slingluff, Jr | 2004-11-04 |
| SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma (NCT00095953) | NCIC Clinical Trials Group | 2004-11-01 |
| ABT-510 in Treating Patients With Metastatic Melanoma (NCT00602199) | Mayo Clinic | 2004-11-01 |
| Vaccine Therapy in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma (NCT00104845) | Memorial Sloan Kettering Cancer Center | 2004-09-01 |
| Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00091338) | National Cancer Institute (NCI) | 2004-08-01 |
| Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma (NCT00091143) | Providence Cancer Center, Earle A. Chiles Research Institute | 2004-07-01 |
| Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma (NCT00091104) | National Institutes of Health Clinical Center (CC) | 2004-07-01 |
| Computer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or Weight Control (NCT00295906) | Rhode Island Hospital | 2004-06-01 |
| Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery (NCT00450372) | University of Miami | 2004-06-01 |
| Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma (NCT00084656) | Bristol-Myers Squibb | 2004-05-31 |
| Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00085462) | National Institutes of Health Clinical Center (CC) | 2004-05-01 |
| Boron Neutron Capture Therapy Using Boronophenylalanine-Fructose Complex in Treating Patients With Metastatic Melanoma (NCT00085059) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-04-01 |
| CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery (NCT00090896) | Jonsson Comprehensive Cancer Center | 2004-04-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00085397) | Dana-Farber Cancer Institute | 2004-03-01 |
| Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00085579) | Memorial Sloan Kettering Cancer Center | 2004-03-01 |
| Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma (NCT00077532) | National Institutes of Health Clinical Center (CC) | 2004-03-01 |
| Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer (NCT00082914) | National Cancer Institute (NCI) | 2004-03-01 |
| Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00085423) | Dartmouth-Hitchcock Medical Center | 2004-02-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00085488) | Dartmouth-Hitchcock Medical Center | 2004-02-01 |
| ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma (NCT00081042) | Jonsson Comprehensive Cancer Center | 2004-02-01 |
| PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma (NCT00049530) | Eastern Cooperative Oncology Group | 2004-01-13 |
| PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma (NCT00073892) | Cellxpert Biotechnology Corp. | 2004-01-01 |
| Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System (NCT00068666) | Alliance for Clinical Trials in Oncology | 2004-01-01 |
| Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00079144) | National Cancer Institute (NCI) | 2004-01-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00334776) | University of Southern California | 2003-10-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma (NCT00089193) | Craig L Slingluff, Jr | 2003-09-01 |
| Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma (NCT00072124) | National Cancer Institute (NCI) | 2003-09-01 |
| Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma (NCT00072085) | National Cancer Institute (NCI) | 2003-09-01 |
| Fotemustine in Treating Patients With Metastatic Melanoma (NCT00560118) | Institut du Cancer de Montpellier - Val d'Aurelle | 2003-08-08 |
| Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301 (NCT00070343) | Jonsson Comprehensive Cancer Center | 2003-08-01 |
| Temozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV Melanoma (NCT00072345) | Memorial Sloan Kettering Cancer Center | 2003-07-01 |
| Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma (NCT00074230) | University Hospital Erlangen | 2003-07-01 |
| Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma (NCT00089219) | University of Virginia | 2003-07-01 |
| Perifosine in Treating Patients With Metastatic or Recurrent Malignant Melanoma (NCT00053781) | NCIC Clinical Trials Group | 2003-06-20 |
| Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma (NCT00062036) | National Institutes of Health Clinical Center (CC) | 2003-06-01 |
| Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma (NCT00317759) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00058279) | National Cancer Institute (NCI) | 2003-02-01 |
| Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00054535) | National Cancer Institute (NCI) | 2003-01-01 |
| Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes (NCT01082198) | Maria Sklodowska-Curie National Research Institute of Oncology | 2002-10-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00045149) | Fred Hutchinson Cancer Center | 2002-10-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00056134) | University Hospital Erlangen | 2002-10-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00053391) | University Hospital Erlangen | 2002-10-01 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00042783) | SWOG Cancer Research Network | 2002-09-01 |
| Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver (NCT00039234) | Maxim Pharmaceuticals | 2002-09-01 |
| Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma (NCT00049010) | Alliance for Clinical Trials in Oncology | 2002-09-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery (NCT00089206) | University of Virginia | 2002-08-01 |
| Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain (NCT00039572) | Beth Israel Deaconess Medical Center | 2002-05-01 |
| Boron Neutron Capture Therapy in Treating Patients With Melanoma (NCT00059800) | Beth Israel Deaconess Medical Center | 2002-05-01 |
| Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma (NCT00039325) | Jonsson Comprehensive Cancer Center | 2002-03-01 |
| Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma (NCT00031733) | University of Southern California | 2002-02-01 |
| Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00033228) | Mannkind Corporation | 2002-01-01 |
| Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma (NCT00026520) | SWOG Cancer Research Network | 2001-11-01 |
| Biological Therapy in Treating Patients With Metastatic Melanoma (NCT00045357) | Fred Hutchinson Cancer Center | 2001-11-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma (NCT00037037) | Herbert Irving Comprehensive Cancer Center | 2001-10-01 |
| Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery (NCT00025181) | University of Southern California | 2001-10-01 |
| Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors (NCT00003750) | Children's Oncology Group | 2001-10-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00022568) | Herbert Irving Comprehensive Cancer Center | 2001-08-01 |
| CCI-779 in Treating Patients With Metastatic Melanoma (NCT00022464) | City of Hope Medical Center | 2001-06-01 |
| Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment (NCT00022438) | National Cancer Institute (NCI) | 2001-06-01 |